Cost effectiveness and tolerability of dose dense versus weekly paclitaxel chemotherapy in patients with early breast cancer: A real-world comparison.

e18264Background: Paclitaxel (PAC) regimens used in early breast cancer include 3-weekly, 2-weekly dose-dense (dd) and weekly regimens. Both dd x4 and weekly x12 regimens are superior to the 3-week...